Intralesional application of recombinant human tumor necrosis factor alpha induces local tumor regression in patients with advanced malignancies

European Journal of Cancer and Clinical Oncology

Volumn 25, Issue 2, 1989, Pages

  Bartsch, Helge H ^a   Pfizenmaier, Klaus ^b   Schroeder, Michael ^a   Nagel, Gerd A ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b MAX PLANCK INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR;

ADULT; CLINICAL ARTICLE; FEMALE; FEVER; HUMAN; INTRATUMORAL DRUG ADMINISTRATION; MALE; METASTASIS; SOLID TUMOR;

ADOLESCENT; ADULT; AGED; CARCINOMA, SMALL CELL; CLINICAL TRIALS; DRUG RESISTANCE; FEMALE; HUMAN; INJECTIONS; LUNG NEOPLASMS; MALE; MIDDLE AGE; NEOPLASMS; SUPPORT, NON-U.S. GOV'T; TUMOR NECROSIS FACTOR;

EID: 0024586212     PISSN: 02775379     EISSN: None     Source Type: Journal    
DOI: 10.1016/0277-5379(89)90021-7     Document Type: Article

References (16)

1. Tumor necrosis factor (TNF)
2. Cachectin and tumour necrosis factor as two sides of the same biological coin
3. Tumor necrosis factor (TNF) alpha: control of TNF sensitivity and molecular mechanisms of TNF-mediated growth inhibition
4. Biology of disease
5. Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro
6. Antitumor activity of murine tumor necrosis factor (RNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice
7. Human tumor necrosis factor: production, purification, and characterization
8. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin
9. Phase I study of recombinant tumor necrosis factor in cancer patients
10. Phase I clinical trial of recombinant tumor necrosis factor
11. Phase I study of recombinant human tumor necrosis factor-alpha in patients with advanced malignancies
12. Serum-free in vitro bioassay for the detection of tumor necrosis factor
13. Tumor necrosis factor inhibits MYC expression in HL-60 cells at the level of mRNA transcription
14. Tumor necrosis factor-induced changes of gene expression in U937 cells
15. Tumor necrosis factor in experimental cancer regression with alpha-tocopherol, beta-carotene, canthaxanthin and algae extract
16. Dominance of resistance to the cytocidal effect of tumor necrosis factor in heterocaryons formed by fusion of resistant and sensitive cells